IONS vs MEDP · rev $514.0M vs P/E 25, rev $707.3M
Ionis Pharmaceuticals Inc (IONS) versus Medpace Holdings Inc (MEDP) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Medpace Holdings Inc (MEDP) is a diagnostics & research company listed on US.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
Latest reported MEDP revenue for 2026-06-30 was $707.3M. Net income was $121.4M. Revenue was up 0.1% from 2026-03-31 to 2026-06-30. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
IONS currently screens at market cap $12.28B. MEDP currently screens at market cap $9.30B and trailing P/E 24.7.
Not investment advice. Open the IONS and MEDP stock pages for the full models.
Not investment advice.